SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-18-008297
Filing Date
2018-06-07
Accepted
2018-06-07 06:18:02
Documents
52

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 1274546
2 ex5-1.htm EX-5.1 11739
3 ex21-1.htm EX-21.1 4925
4 ex23-1.htm EX-23.1 5343
5 logo_001.jpg GRAPHIC 7688
6 ex5-1_001.jpg GRAPHIC 18963
7 ex23-1_001.jpg GRAPHIC 12947
  Complete submission text file 0001493152-18-008297.txt   3235353

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ntva-20180331.xml EX-101.INS 270799
9 XBRL SCHEMA FILE ntva-20180331.xsd EX-101.SCH 28089
10 XBRL CALCULATION FILE ntva-20180331_cal.xml EX-101.CAL 31078
11 XBRL DEFINITION FILE ntva-20180331_def.xml EX-101.DEF 156765
12 XBRL LABEL FILE ntva-20180331_lab.xml EX-101.LAB 172355
13 XBRL PRESENTATION FILE ntva-20180331_pre.xml EX-101.PRE 194635
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
Intiva BioPharma Inc. (Filer) CIK: 0001625288 (see all company filings)

IRS No.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-225477 | Film No.: 18885141
SIC: 2834 Pharmaceutical Preparations